SQUAWK/NEWS
Menu
Live News EQUITY L impact

SRPT Sarepta Therapeutics appoints Michael severino, M.D., Chief Executive Officer Sarepta Therapeutics - Doug ingram to retire and serve as

SRPT Sarepta Therapeutics appoints Michael severino, M.D., Chief Executive Officer Sarepta Therapeutics - Doug ingram to retire and serve as advisor until end of 2026

SRPT

SRPT Sarepta Therapeutics appoints Michael severino, M.D., Chief Executive Officer Sarepta Therapeutics - Doug ingram to retire and serve as advisor until end of 2026